COMBINATION CANCER THERAPY

Details for Australian Patent Application No. 2002351382 (hide)

Owner PHARMACYCLICS, INC.

Inventors FAN, Qing

Pub. Number AU-A-2002351382

PCT Number PCT/US02/40016

PCT Pub. Number WO2003/049743

Priority 60/339,649 13.12.01 US

Filing date 13 December 2002

Wipo publication date 23 June 2003

International Classifications

A61K 031/555 - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/535 - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 031/70 - Carbohydrates

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/339,649 13.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002351382

2 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351383-INITIATION SEQUENCES FOR PERFORMING PROTECTED COMPUTER OPERATIONS

2002351381-Method for treating circadian rhythm disruptions